SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Orchid Pharma

Orchid Pharma

BSE: 524372|NSE: ORCHIDPHAR|ISIN: INE191A01019|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 20, 16:00
29.20
1.45 (5.23%)
VOLUME 467,095
LIVE
NSE
Feb 20, 15:55
29.20
1.45 (5.23%)
VOLUME 1,812,421
News on Orchid Pharma
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Exit Orchid Pharma; pick Lupin, Sun Pharma: Avinash Gorakshakar 

3.26 pm | 20 Feb 2017 |  Source: CNBC-TV18

Avinash Gorakshakar, Market Expert advises exiting Orchid Pharma and one can prefer Lupin and Sun Pharmaceutical Industries....

Exit Orchid Pharma closer to Rs 36: Prakash Gaba 

3.25 pm | 20 Feb 2017 |  Source: CNBC-TV18

According to Prakash Gaba of prakashgaba.com, one may exit Orchid Pharma closer to Rs 36....

Stocks in news: Infosys, Axis, Tata Steel, Bharti, Quess, Titan 

8.00 am | 08 Feb 2017 |  Source: CNBC-TV18

Infosys | Idea Cellular | Axis Bank | Tata Steel | Bharti Airtel | Bharat Forge | Hero Motocorp | Godawari Power | Jubilant Life Sciences | NHPC | Que...

Orchid Pharma Q3 net loss narrows to Rs 60.97 cr

4.28 pm | 07 Feb 2017 |  Source: PTI

The company had posted a net loss of Rs 94.02 crore in the year-ago period, Orchid Pharma said in a BSE filing....

Orchid Pharma's board meeting on February 07, 2017

12.10 pm | 30 Jan 2017 |  Source: Moneycontrol.com

Orchid Pharma Ltd has informed BSE that a meeting of the Board of Directors is proposed to be held on February 07, 2017, to approve the unaudited fina...

1 2
Quick Links for Orchid Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.